Case Studies On Reiki
The Efficacy of Reiki in the Treatment of Fibromyalgia
This study is no longer recruiting patients.
Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)
Purpose
The purpose of this study is to investigate the effectiveness of Reiki in the treatment of fibromyalgia (FM), a condition characterized by widespread muscle pain and stiffness, often accompanied by sleep disturbance, headaches, irritable bowel syndrome, and psychological distress. Reiki is a form of energy medicine in which practitioners reportedly access universal life energy to heal patients, either by direct contact at specific hand positions or from a distance.
Condition Treatment or Intervention Phase
Fibromyalgia
Procedure: Reiki (distant and direct-contact)
Phase I
MedlinePlus related topics: Fibromyalgia
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Expected Total Enrollment: 100
Study start: January 2003
Fibromyalgia is one of the most common rheumatologic diagnoses. Treatment is generally unsatisfactory and most randomized, controlled treatment trials have been unable to demonstrate a sustained effective intervention. A vast body of anecdotal literature as well as two randomized controlled trials suggest that Reiki may be an effective treatment for FM, appearing to relieve pain and improve psychological well being. Reiki appears to have no adverse effects and can eventually be self-administered, making it a low-risk, low-cost, potentially patient-empowering intervention. This study will investigate the efficacy of Reiki in the treatment of FM.
One hundred Reiki-naive FM patients will be recruited from a chronic fatigue referral clinic and will participate in an 8-week trial. Patients will be randomized into one of two Reiki groups (direct-contact and distant Reiki) or one of two control groups (sham and placebo). Patients will receive either Reiki or placebo 16 times during the course of the study. Patients will be assessed at study entry, at Weeks 4 and 8, and 12 weeks post-treatment.
Eligibility
Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
Fibromyalgia without concurrent medical conditions associated with chronic pain, such as diabetic neuropathy, systemic lupus erythematosus, or severe degenerative joint disease
Willing to undergo randomization and attend treatments regularly
Willing to stay on a stable medical regimen during the entire 8-week trial and use only acetaminophen for breakthrough pain
Live within a one-hour drive of the study site
Exclusion Criteria
Received Reiki or any other energy medicine (Therapeutic Touch, Qi Gong, SHEN Therapy, etc.)
Pregnant
Pending litigation or disability claim related to FM
Location Information
Washington
Univ of WA - CFS/FM Research Center, Seattle, Washington, 98104, United States
Study chairs or principal investigators
Dedra S. Buchwald, Principal Investigator
More Information
Study ID Numbers: 1 R21 AT01075-01
Record last reviewed: January 2005
Last Updated: January 12, 2005
Record first received: January 9, 2003
ClinicalTrials.gov Identifier: NCT00051428
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-06-10
|
